Orthofix Medical (OFIX) Short term Debt (2010 - 2024)

Orthofix Medical has disclosed Short term Debt across 10 years of filings, most recently posting $7.1 million for Q4 2024.

• Quarterly Short term Debt rose 468.0% year-over-year to $7.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $7.1 million (up 468.0% YoY) and the FY2024 annual result came in at $7.1 million, up 468.0% from the prior year.
• Short term Debt advanced to $7.1 million in Q4 2024, from $6.2 million in the prior quarter.
• Over five years, Short term Debt peaked at $17.2 million in Q4 2021 and troughed at $1.0 million in Q4 2022.
• A 5-year average of $6.9 million and a median of $5.5 million in 2024 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2022 — Short term Debt tumbled 94.19% — and 2024, when it surged 468.0%.
• Tracing OFIX's Short term Debt over 5 years: stood at $14.9 million in 2020, then rose by 15.44% to $17.2 million in 2021, then slumped by 94.19% to $1.0 million in 2022, then increased by 25.0% to $1.2 million in 2023, then jumped by 468.0% to $7.1 million in 2024.
• Business Quant data shows OFIX's Short term Debt at $7.1 million in Q4 2024, $6.2 million in Q3 2024, and $4.7 million in Q2 2024.